make a note of retinal vasculitis from very basics to advanced level including clinical trials and recent advances. Start from the basics, ask questions then proceed if the basic is strong in the chat.
Asking for Preferences
Asking for Preferences
Reading File
Finding Sources
Searching PubMed
"retinal vasculitis" AND treatment
Searching the Web
retinal vasculitis recent advances 2024 2025 clinical trials biologic therapy
Reading File
Finding Sources
Reading Article
PMID: 40320076
Reading Article
PMID: 41643758
Reading File
Reading File
Searching PubMed
"retinal vasculitis" AND ("Behcet" OR "sarcoidosis" OR "tuberculosis") AND classification
Reading Web Page
https://eyewiki.org/Retinal_Vasculitis
Reading File
Reading Article
PMID: 36625549
Reading Article
PMID: 36893438
Your comprehensive note is ready. Here is a brief orientation to what was covered:
What's in Your Note (16 Sections)
Basics (Sections 1-3): Retinal anatomy, BRB, definition, history (Eales 1880), epidemiology from the latest IUSG data (7619 patients, 2025).
Classification (Section 4): Three-level classification - by etiology (infectious/non-infectious/idiopathic), by vessel (arteritis vs. periphlebitis vs. capillaritis), and the brand-new IUSG ReViSe framework (2025).
Pathophysiology (Section 5): Step-by-step BRB breakdown, T-cell mediated mechanism, cytokine cascade (TNF, IL-6, IL-17, VEGF), why Type III hypothesis is now discarded.
Clinical Features (Sections 6-7): All signs in detail + deep dives on Eales, IRVAN, Behcet, Sarcoidosis, and Birdshot.
Investigations (Section 8): FFA findings in sequence, OCT, ERG, full systemic workup table with HLA associations.
Management (Sections 9-11): Three-step approach (steroids → steroid-sparing → biologics), full drug table, PRP indications.
Recent Advances (Sections 12-13):
- Brolucizumab-RV (Wykoff 2023 systematic review - 77.8% women, 30-day onset)
- Vancomycin HORV
- 2026 RCT (Saadoun et al.) - Adalimumab = Tocilizumab; Anakinra = ineffective
- Adalimumab meta-analysis (Sener 2024) for Behcet
- OCT-A, wide-field FFA, metagenomics
- JAK inhibitors and IL-17 pathway drugs (emerging)
High-Yield (Sections 14-16): Mnemonics, differential diagnosis, prognosis table.
Shall we proceed to a Q&A/viva round on retinal vasculitis to test what you've learned, or would you like to go deeper into any specific section?
start with basics both anatomy and physiology in simple words so i don't have to revise for the longer time. also make exam ready note for it with diagrams, flowcharts( i am final year resident, so i want to top my exam)
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Your full exam-ready basics note is above. Here's what's packed in:
What You Just Got (Quick Index)
| Section | What's Inside |
|---|---|
| Part 1 - Anatomy | Eye in 30 sec, all 10 retinal layers with ASCII diagram, cell types with relay chain diagram, Rods vs. Cones full comparison table, dual blood supply with BRB table, Macula/Fovea/Disc hotspots |
| Part 2 - Physiology | Dark current concept (demystified), full phototransduction flowchart (10 steps), Rhodopsin pigments, Dark/Light adaptation with Kohlrausch kink, Visual pathway + field defect flowchart, Pupillary reflex circuit, IOP regulation with drug mechanism flowchart, Near triad (accommodation) |
| Part 3 - Bridge to RV | Why vasculitis causes each symptom (mechanism map), which layer is damaged in which disease, FFA interpretation logic |
| Quick Cards | 7 last-night revision cards |
| Viva Q&A | 8 high-yield questions with model answers |
What's next?
- Want a viva drill specifically on these basics before moving to clinical RV?
- Or should we go directly into the clinical section of RV (classification + pathophysiology in the same exam-ready format)?
- I can also generate a PDF study sheet with all diagrams formatted neatly.
continue
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Your clinical masterclass note is complete. Here's what Parts 4-8 cover:
Index of This Section
| Part | Content |
|---|---|
| Part 4 | Definition (exam-perfect wording), Master classification chart (by vessel + etiology), Pathophysiology flowchart (with old vs. current mechanism) |
| Part 5 | Symptoms (with the "no pain" rule), Full fundus sign map, Special signs (Frosted branch, Candlewax, Pizza pie) |
| Part 6 | Master comparison table (Eales/Behcet/Sarcoid/ARN/IRVAN), Deep dive on each - stages, who, treatment, prognosis; ARN vs PORN comparison |
| Part 7 | FFA phase-by-phase guide for RV, OCT/OCT-A findings, Complete systemic workup table with all HLA associations |
| Part 8 | Full management flowchart (rule out infection FIRST principle), Complication management table, PRP indications |
| Part 9 | 15 rapid-fire viva Q&As with model answers, Single-page last-night cheat sheet |
Together with Part 1-3 (previous session), you now have a complete, exam-ready note covering:
- Basics (anatomy + physiology)
- Clinical RV (classification to management)
- Recent advances (2025-2026 trials)
- 23 viva Q&As with model answers
Ready to do a viva drill now? I'll fire questions at you exactly the way an examiner would - starting simple and escalating to trap questions and clinical scenarios. Just say "fire away" or tell me a specific area you want to be tested on.
i don't think the physiology part has been completed
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
The physiology section is now complete. Here is what was added:
What This Section Added (Sections 2.9-2.22)
| Section | Topic |
|---|---|
| 2.9 | ON/OFF bipolar cells - different glutamate receptors (ionotropic vs mGluR6), dark vs light behavior |
| 2.10 | Center-surround receptive fields - formation, logic, clinical meaning (edge detection) |
| 2.11 | M / P / K ganglion cell types - size, pathway, function, Dorsal "WHERE" vs Ventral "WHAT" |
| 2.12 | Color vision - trichromacy theory, opponent channels, color blindness table, tests |
| 2.13 | Müller cell physiology - K+ buffering, glutamate recycling, b-wave generation, light guidance |
| 2.14 | RPE functions (7) - phagocytosis, visual cycle, BRB, fluid transport, PEDF/VEGF balance |
| 2.15 | Retinal oxygenation - why outer retina is avascular, autoregulation of CRA, why RP starts peripherally |
| 2.16 | ERG complete - a/b/c waves with origins, oscillatory potentials, 6-step ISCEV protocol, disease table |
| 2.17 | EOG - Arden ratio, Best disease (normal ERG + abnormal EOG) |
| 2.18 | VEP - P100 wave, delayed vs reduced, MS/optic neuritis vs functional loss |
| 2.19 | Master electrophysiology comparison table (ERG/EOG/VEP/mfERG/PERG) |
| 2.20 | Color vision testing (Ishihara, FM100, Nagel anomaloscope) |
| 2.21 | Dark adaptation curve with diagram and Kohlrausch kink |
| 2.22 | 8 new revision cards (Cards 8-15) + 7 new viva Q&As (Q16-Q22) |
The physiology is now truly complete. Combined with the earlier sections, you have 22 viva Q&As and a full anatomy-to-advanced-physiology-to-clinical-RV note chain ready for your exam.
This is a shared conversation. Sign in to Orris to start your own chat.